Andrea Mancini

Dr. Andrea Mancini

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2018 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
MFMassimiliano Di Filippo
Massimiliano Di Filippo
EPEmilio Portaccio
Emilio Portaccio
AMAndrea Mancini
Andrea Mancini
PCPaolo Calabresi
Paolo Calabresi

18 February 2016 in Scientific Reports
Verified
Journal Article
Open access
MFMassimiliano Di Filippo
Massimiliano Di Filippo
AIAntonio de iure
Antonio de iure
CGCarmela Giampà
Carmela Giampà
DCDavide Chiasserini
Davide Chiasserini
ATAlessandro Tozzi
Alessandro Tozzi
PCPaolo Calabresi
Paolo Calabresi
Cognitive impairment is common in multiple sclerosis (MS). Unfortunately, the synaptic and molecular mechanisms underlying MS-associated cognitive dysfunction are largely unknown. We explored the presence and the underlying mechanism of cognitive and synaptic hippocampal dysfunction during the remission phase of experimental MS. Experiments were performed in a chronic-relapsing experimental autoimmune encephalomyelitis (EAE) model of MS, after the resolution of motor deficits. Immunohistochemistry and patch-clamp recordings were performed in the CA1 hippocampal area. The hole-board was utilized as cognitive/behavioural test. In the remission phase of experimental MS, hippocampal microglial cells showed signs of activation, CA1 hippocampal synapses presented an impaired long-term potentiation (LTP) and an alteration of spatial tests became evident. The activation of hippocampal microglia mediated synaptic and cognitive/behavioural alterations during EAE. Specifically, LTP blockade was found to be caused by the reactive oxygen species (ROS)-producing enzyme nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. We suggest that in the remission phase of experimental MS microglia remains activated, causing synaptic dysfunctions mediated by NADPH oxidase. Inhibition of microglial activation and NADPH oxidase may represent a promising strategy to prevent neuroplasticity impairment associated with active neuro-inflammation, with the aim to improve cognition and counteract MS disease progression.

1 February 2020 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
LGLorenzo Gaetani
Lorenzo Gaetani
MCMarinella Di Carlo
Marinella Di Carlo
GBGiovanni Brachelente
Giovanni Brachelente
FVFederico Valletta
Federico Valletta
PEPaolo Eusebi
Paolo Eusebi
MFMassimiliano Di Filippo
Massimiliano Di Filippo

Verified
Journal Article
Open access
PDF file
GMGiulia Menculini
Giulia Menculini
ECElena Chipi
Elena Chipi
FPFederico Paolini Paoletti
Federico Paolini Paoletti
LGLorenzo Gaetani
Lorenzo Gaetani
PNPasquale Nigro
Pasquale Nigro
Parnetti LucillaParnetti Lucilla
Parnetti Lucilla
Different psychopathological manifestations, such as affective, psychotic, obsessive-compulsive symptoms, and impulse control disturbances, may occur in most central nervous system (CNS) disorders including neurodegenerative and neuroinflammatory diseases. Psychiatric symptoms often represent the clinical onset of such disorders, thus potentially leading to misdiagnosis, delay in treatment, and a worse outcome. In this review, psychiatric symptoms observed along the course of several neurological diseases, namely Alzheimer’s disease, fronto-temporal dementia, Parkinson’s disease, Huntington’s disease, and multiple sclerosis, are discussed, as well as the involved brain circuits and molecular/synaptic alterations. Special attention has been paid to the emerging role of fluid biomarkers in early detection of these neurodegenerative diseases. The frequent occurrence of psychiatric symptoms in neurological diseases, even as the first clinical manifestations, should prompt neurologists and psychiatrists to share a common clinico-biological background and a coordinated diagnostic approach.

8 September 2018 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
LGLorenzo Gaetani
Lorenzo Gaetani
LPLuca Prosperini
Luca Prosperini
AMAndrea Mancini
Andrea Mancini
PEPaolo Eusebi
Paolo Eusebi
MCMaria Chiara Cerri
Maria Chiara Cerri
MFMassimiliano Di Filippo
Massimiliano Di Filippo

Verified
Journal Article
Open access
PDF file
LBLaura Bellingacci
Laura Bellingacci
AMAndrea Mancini
Andrea Mancini
LGLorenzo Gaetani
Lorenzo Gaetani
ATAlessandro Tozzi
Alessandro Tozzi
Parnetti LucillaParnetti Lucilla
Parnetti Lucilla
MFMassimiliano Di Filippo
Massimiliano Di Filippo
Multiple sclerosis (MS) has been clinically considered a chronic inflammatory disease of the white matter; however, in the last decade growing evidence supported an important role of gray matter pathology as a major contributor of MS-related disability and the involvement of synaptic structures assumed a key role in the pathophysiology of the disease. Synaptic contacts are considered central units in the information flow, involved in synaptic transmission and plasticity, critical processes for the shaping and functioning of brain networks. During the course of MS, the immune system and its diffusible mediators interact with synaptic structures leading to changes in their structure and function, influencing brain network dynamics. The purpose of this review is to provide an overview of the existing literature on synaptic involvement during experimental and human MS, in order to understand the mechanisms by which synaptic failure eventually leads to brain networks alterations and contributes to disabling MS symptoms and disease progression.